The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch

REFERENCES

• Naylor RM, van Deursen JM. 2016. Aneuploidy in cancer and aging. Annu Rev Genet 50:45–66. https://doi.org/10.1146/annurev-genet-120215-035303.
   PubMed Web of Science ®Google Scholar
• Kettenbach AN, Schweppe DK, Faherty BK, Pechenick D, Pletnev AA, Gerber SA. 2011. Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal 4:rs5. https://doi.org/10.1126/scisignal.2001497.
   PubMed Web of Science ®Google Scholar
• Dephoure N, Zhou C, Villén J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP. 2008. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105:10762–10767. https://doi.org/10.1073/pnas.0805139105.
   PubMed Web of Science ®Google Scholar
• Wurzenberger C, Gerlich DW. 2011. Phosphatases: providing safe passage through mitotic exit. Nat Rev Mol Cell Biol 12:469–482. https://doi.org/10.1038/nrm3149.
   PubMed Web of Science ®Google Scholar
• King RW, Peters JM, Tugendreich S, Rolfe M, Hieter P, Kirschner MW. 1995. A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 81:279–288. https://doi.org/10.1016/0092-8674(95)90338-0.
   PubMed Web of Science ®Google Scholar
• Sudakin V, Ganoth D, Dahan A, Heller H, Hershko J, Luca FC, Ruderman JV, Hershko A. 1995. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol Biol Cell 6:185–197. https://doi.org/10.1091/mbc.6.2.185.
   PubMed Web of Science ®Google Scholar
• Irniger S, Piatti S, Michaelis C, Nasmyth K. 1995. Genes involved in sister chromatid separation are needed for B-type cyclin proteolysis in budding yeast. Cell 81:269–278. https://doi.org/10.1016/0092-8674(95)90337-2.
   PubMed Web of Science ®Google Scholar
• Dou Z, von Schubert C, Körner R, Santamaria A, Elowe S, Nigg EA. 2011. Quantitative mass spectrometry analysis reveals similar substrate consensus motif for human Mps1 kinase and Plk1. PLoS One 6:e18793. https://doi.org/10.1371/journal.pone.0018793.
   Google Scholar
• Hayward D, Alfonso-Pérez T, Cundell MJ, Hopkins M, Holder J, Bancroft J, Hutter LH, Novak B, Barr FA, Gruneberg U. 2019. CDK1-CCNB1 creates a spindle checkpoint-permissive state by enabling MPS1 kinetochore localization. J Cell Biol 218:1182–1199. https://doi.org/10.1083/jcb.201808014.
   PubMed Web of Science ®Google Scholar
• Gharbi-Ayachi A, Labbé J-C, Burgess A, Vigneron S, Strub J-M, Brioudes E, Van-Dorsselaer A, Castro A, Lorca T. 2010. The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A. Science 330:1673–1677. https://doi.org/10.1126/science.1197048.
   PubMed Web of Science ®Google Scholar
• Blake-Hodek KA, Williams BC, Zhao Y, Castilho PV, Chen W, Mao Y, Yamamoto TM, Goldberg ML. 2012. Determinants for activation of the atypical AGC kinase Greatwall during M phase entry. Mol Cell Biol 32:1337–1353. https://doi.org/10.1128/MCB.06525-11.
   PubMed Web of Science ®Google Scholar
• Vigneron S, Gharbi-Ayachi A, Raymond A-A, Burgess A, Labbé J-C, Labesse G, Monsarrat B, Lorca T, Castro A. 2011. Characterization of the mechanisms controlling Greatwall activity. Mol Cell Biol 31:2262–2275. https://doi.org/10.1128/MCB.00753-10.
   PubMed Web of Science ®Google Scholar
• Mailand N, Podtelejnikov AV, Groth A, Mann M, Bartek J, Lukas J. 2002. Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J 21:5911–5920. https://doi.org/10.1093/emboj/cdf567.
   PubMed Web of Science ®Google Scholar
• Wu Z, Jiang Q, Clarke PR, Zhang C. 2013. Phosphorylation of Crm1 by CDK1–cyclin-B promotes Ran-dependent mitotic spindle assembly. J Cell Sci 126:3417–3428. https://doi.org/10.1242/jcs.126854.
   PubMed Web of Science ®Google Scholar
• Grzechnik AT, Newton AC. 2016. PHLPPing through history: a decade in the life of PHLPP phosphatases. Biochem Soc Trans 44:1675–1682. https://doi.org/10.1042/BST20160170.
   PubMed Web of Science ®Google Scholar
• Chen MJ, Dixon JE, Manning G. 2017. Genomics and evolution of protein phosphatases. Sci Signal 10:eaag1796. https://doi.org/10.1126/scisignal.aag1796.
   Google Scholar
• Gao T, Furnari F, Newton AC. 2005. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18:13–24. https://doi.org/10.1016/j.molcel.2005.03.008.
   PubMed Web of Science ®Google Scholar
• Brognard J, Sierecki E, Gao T, Newton AC. 2007. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25:917–931. https://doi.org/10.1016/j.molcel.2007.02.017.
   PubMed Web of Science ®Google Scholar
• Goel A, Arnold CN, Niedzwiecki D, Chang DK, Ricciardiello L, Carethers JM, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM, Boland CR. 2003. Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res 63:1608–1614.
   PubMed Web of Science ®Google Scholar
• Johnson-Pais TL, Nellissery MJ, Ammerman DG, Pathmanathan D, Bhatia P, Buller CL, Leach RJ, Hansen MF. 2003. Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma. Int J Cancer 105:285–288. https://doi.org/10.1002/ijc.11070.
   PubMed Web of Science ®Google Scholar
• Rakha EA, Green AR, Powe DG, Roylance R, Ellis IO. 2006. Chromosome 16 tumor-suppressor genes in breast cancer. Genes Chromosomes Cancer 45:527–535. https://doi.org/10.1002/gcc.20318.
   PubMed Web of Science ®Google Scholar
• Tørring N, Borre M, Sørensen KD, Andersen CL, Wiuf C, Ørntoft TF. 2007. Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array. Br J Cancer 96:499–506. https://doi.org/10.1038/sj.bjc.6603476.
   PubMed Web of Science ®Google Scholar
• Chen M, Pratt CP, Zeeman ME, Schultz N, Taylor BS, O'Neill A, Castillo-Martin M, Nowak DG, Naguib A, Grace DM, Murn J, Navin N, Atwal GS, Sander C, Gerald WL, Cordon-Cardo C, Newton AC, Carver BS, Trotman LC. 2011. Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell 20:173–186. https://doi.org/10.1016/j.ccr.2011.07.013.
   PubMed Web of Science ®Google Scholar
• Li X, Stevens PD, Liu J, Yang H, Wang W, Wang C, Zeng Z, Schmidt MD, Yang M, Lee EY, Gao T. 2014. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice. Gastroenterology 146:1301–1312.E10. https://doi.org/10.1053/j.gastro.2014.02.003.
   PubMed Web of Science ®Google Scholar
• Liu J, Stevens PD, Li X, Schmidt MD, Gao T. 2011. PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth. Mol Cell Biol 31:4917–4927. https://doi.org/10.1128/MCB.05799-11.
   PubMed Web of Science ®Google Scholar
• Baffi TR, Van AN, Zhao W, Mills GB, Newton AC. 2019. Protein kinase C quality control by phosphatase PHLPP1 unveils loss-of-function mechanism in cancer. Mol Cell 74:378–392.E5. https://doi.org/10.1016/j.molcel.2019.02.018.
   PubMed Web of Science ®Google Scholar
• Gao T, Brognard J, Newton AC. 2008. The phosphatase PHLPP controls the cellular levels of protein kinase C. J Biol Chem 283:6300–6311. https://doi.org/10.1074/jbc.M707319200.
   PubMed Web of Science ®Google Scholar
• Cohen Katsenelson K, Stender JD, Kawashima AT, Lordén G, Uchiyama S, Nizet V, Glass CK, Newton AC. 2019. PHLPP1 counter-regulates STAT1-mediated inflammatory signaling. Elife 8:e48609. https://doi.org/10.7554/eLife.48609.
   PubMed Web of Science ®Google Scholar
• Reyes G, Niederst M, Cohen-Katsenelson K, Stender JD, Kunkel MT, Chen M, Brognard J, Sierecki E, Gao T, Nowak DG, Trotman LC, Glass CK, Newton AC. 2014. Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output. Proc Natl Acad Sci U S A 111:E3957–E3965. https://doi.org/10.1073/pnas.1404221111.
   PubMed Web of Science ®Google Scholar
• Patterson SJ, Han JM, Garcia R, Assi K, Gao T, O'Neill A, Newton AC, Levings MK. 2011. Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. J Immunol 186:5533–5537. https://doi.org/10.4049/jimmunol.1002126.
   PubMed Web of Science ®Google Scholar
• Hwang SM, Feigenson M, Begun DL, Shull LC, Culley KL, Otero M, Goldring MB, Ta LE, Kakar S, Bradley EW, Westendorf JJ. 2018. Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis. J Orthop Res 36:1487–1497. https://doi.org/10.1002/jor.23781.
   PubMed Web of Science ®Google Scholar
• Bradley EW, Carpio LR, Westendorf JJ. 2013. Histone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (Phlpp)1 expression in chondrocytes to suppress Akt signaling and matrix secretion. J Biol Chem 288:9572–9582. https://doi.org/10.1074/jbc.M112.423723.
   PubMed Web of Science ®Google Scholar
• Bradley EW, Carpio LR, Newton AC, Westendorf JJ. 2015. Deletion of the PH-domain and leucine-rich repeat protein phosphatase 1 (Phlpp1) increases fibroblast growth factor (Fgf) 18 expression and promotes chondrocyte proliferation. J Biol Chem 290:16272–16280. https://doi.org/10.1074/jbc.M114.612937.
   PubMed Web of Science ®Google Scholar
• Gangula NR, Maddika S. 2017. Interplay between the phosphatase PHLPP1 and E3 ligase RNF41 stimulates proper kinetochore assembly via the outer-kinetochore protein SGT1. J Biol Chem 292:13947–13958. https://doi.org/10.1074/jbc.M117.782896.
   PubMed Web of Science ®Google Scholar
• Li X, Yang H, Liu J, Schmidt MD, Gao T. 2011. Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt. EMBO Rep 12:818–824. https://doi.org/10.1038/embor.2011.106.
   PubMed Web of Science ®Google Scholar
• Mészáros B, Erdos G, Dosztányi Z. 2018. IUPred2A: context-dependent prediction of protein disorder as a function of redox state and protein binding. Nucleic Acids Res 46:W329–W337. https://doi.org/10.1093/nar/gky384.
   PubMed Web of Science ®Google Scholar
• Malumbres M. 2014. Cyclin-dependent kinases. Genome Biol 15:122. https://doi.org/10.1186/gb4184.
   PubMed Web of Science ®Google Scholar
• Songyang Z, Blechner S, Hoagland N, Hoekstra MF, Piwnica-Worms H, Cantley LC. 1994. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr Biol 4:973–982. https://doi.org/10.1016/s0960-9822(00)00221-9.
   PubMed Web of Science ®Google Scholar
• Mok J, Kim PM, Lam HYK, Piccirillo S, Zhou X, Jeschke GR, Sheridan DL, Parker SA, Desai V, Jwa M, Cameroni E, Niu H, Good M, Remenyi A, Ma J-LN, Sheu Y-J, Sassi HE, Sopko R, Chan CSM, De Virgilio C, Hollingsworth NM, Lim WA, Stern DF, Stillman B, Andrews BJ, Gerstein MB, Snyder M, Turk BE. 2010. Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs. Sci Signal 3:ra12. https://doi.org/10.1126/scisignal.2000482.
   PubMed Web of Science ®Google Scholar
• Shang C, Hazbun TR, Cheeseman IM, Aranda J, Fields S, Drubin DG, Barnes G. 2003. Kinetochore protein interactions and their regulation by the aurora kinase Ipl1p. Mol Biol Cell 14:3342–3355. https://doi.org/10.1091/mbc.e02-11-0765.
   PubMed Web of Science ®Google Scholar
• Roux KJ, Kim DI, Burke B, May DG. 2018. BioID: a screen for protein-protein interactions. Curr Protoc Protein Sci 91:19.23.1–19.23.15. https://doi.org/10.1002/cpps.51.
   PubMedGoogle Scholar
• Choi-Rhee E, Schulman H, Cronan JE. 2004. Promiscuous protein biotinylation by Escherichia coli biotin protein ligase. Protein Sci 13:3043–3050. https://doi.org/10.1110/ps.04911804.
   PubMed Web of Science ®Google Scholar
• Teo G, Liu G, Zhang J, Nesvizhskii AI, Gingras AC, Choi H. 2014. SAINTexpress: improvements and additional features in significance analysis of INTeractome software. J Proteomics 100:37–43. https://doi.org/10.1016/j.jprot.2013.10.023.
   PubMed Web of Science ®Google Scholar
• Wan S, Meyer AS, Weiler SME, Rupp C, Tóth M, Sticht C, Singer S, Thomann S, Roessler S, Schorpp-Kistner M, Schmitt J, Gretz N, Angel P, Tschaharganeh DF, Marquardt J, Schirmacher P, Pinna F, Breuhahn K. 2018. Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness. Hepatology 67:1842–1856. https://doi.org/10.1002/hep.29669.
   PubMed Web of Science ®Google Scholar
• Zhiqiang Z, Qinghui Y, Yongqiang Z, Jian Z, Xin Z, Haiying M, Yuepeng G. 2012. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells. J Cancer Res Clin Oncol 138:1231–1238. https://doi.org/10.1007/s00432-012-1193-3.
   PubMed Web of Science ®Google Scholar
• Goldbraikh D, Neufeld D, Eid-Mutlak Y, Lasry I, Gilda JE, Parnis A, Cohen S. 2020. USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation. EMBO Rep 21:e48791. https://doi.org/10.15252/embr.201948791.
   Google Scholar
• Zhang X, Lu X, Akhter S, Georgescu MM, Legerski RJ. 2016. FANCI is a negative regulator of Akt activation. Cell Cycle 15:1134–1143. https://doi.org/10.1080/15384101.2016.1158375.
   PubMed Web of Science ®Google Scholar
• Gangula NR, Maddika S. 2013. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1). J Biol Chem 288:34545–34554. https://doi.org/10.1074/jbc.M113.503383.
   PubMed Web of Science ®Google Scholar
• Gagnon D, Lehoux M, Archambault J. 2015. Artificial recruitment of UAF1-USP complexes by a PHLPP1-E1 chimeric helicase enhances human papillomavirus DNA replication. J Virol 89:6227–6239. https://doi.org/10.1128/JVI.00560-15.
   PubMed Web of Science ®Google Scholar
• McClurg UL, Summerscales EE, Harle VJ, Gaughan L, Robson CN. 2014. Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway. Oncotarget 5:7081–7092. https://doi.org/10.18632/oncotarget.2162.
   PubMed Web of Science ®Google Scholar
• Gao G, Kun T, Sheng Y, Qian M, Kong F, Liu X, Yu Z, Zhang H, Zhang Q, Gu J, Zhang X. 2013. SGT1 regulates Akt signaling by promoting beta-TrCP-dependent PHLPP1 degradation in gastric cancer cells. Mol Biol Rep 40:2947–2953. https://doi.org/10.1007/s11033-012-2363-8.
   PubMed Web of Science ®Google Scholar
• Reimand J, Kull M, Peterson H, Hansen J, Vilo J. 2007. g:Profiler—a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res 35:W193–W200. https://doi.org/10.1093/nar/gkm226.
   PubMed Web of Science ®Google Scholar
• Kalsbeek D, Golsteyn RM. 2017. G2/M-phase checkpoint adaptation and micronuclei formation as mechanisms that contribute to genomic instability in human cells. Int J Mol Sci 18:2344. https://doi.org/10.3390/ijms18112344.
   PubMed Web of Science ®Google Scholar
• Santamaría D, Barrière C, Cerqueira A, Hunt S, Tardy C, Newton K, Cáceres JF, Dubus P, Malumbres M, Barbacid M. 2007. Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448:811–815. https://doi.org/10.1038/nature06046.
   PubMed Web of Science ®Google Scholar
• Szmyd R, Niska-Blakie J, Diril MK, Renck Nunes P, Tzelepis K, Lacroix A, van Hul N, Deng L-W, Matos J, Dreesen O, Bisteau X, Kaldis P. 2019. Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality. Oncogene 38:998–1018. https://doi.org/10.1038/s41388-018-0464-0.
   PubMed Web of Science ®Google Scholar
• Piao J, Zhu L, Sun J, Li N, Dong B, Yang Y, Chen L. 2019. High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma. Gene 701:15–22. https://doi.org/10.1016/j.gene.2019.02.081.
   PubMed Web of Science ®Google Scholar
• Ravindran Menon D, Luo Y, Arcaroli JJ, Liu S, KrishnanKutty LN, Osborne DG, Li Y, Samson JM, Bagby S, Tan A-C, Robinson WA, Messersmith WA, Fujita M. 2018. CDK1 interacts with Sox2 and promotes tumor initiation in human melanoma. Cancer Res 78:6561–6574. https://doi.org/10.1158/0008-5472.CAN-18-0330.
   PubMed Web of Science ®Google Scholar
• Yasukawa M, Ando Y, Yamashita T, Matsuda Y, Shoji S, Morioka MS, Kawaji H, Shiozawa K, Machitani M, Abe T, Yamada S, Kaneko MK, Kato Y, Furuta Y, Kondo T, Shirouzu M, Hayashizaki Y, Kaneko S, Masutomi K. 2020. CDK1 dependent phosphorylation of hTERT contributes to cancer progression. Nat Commun 11:1557. https://doi.org/10.1038/s41467-020-15289-7.
   PubMed Web of Science ®Google Scholar
• Heo J, Noh B-J, Lee S, Lee H-Y, Kim Y, Lim J, Ju H, Yu HY, Ryu C-M, Lee PCW, Jeong H, Oh Y, Kim K, Kim S-Y, Son J, Hong B, Kim JS, Cho YM, Shin D-M. 2020. Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis. EMBO Mol Med 12:e10880. https://doi.org/10.15252/emmm.201910880.
   Google Scholar
• Dong S, Huang F, Zhang H, Chen Q. 2019. Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma. Bioscience Rep 39:BSR20182306. https://doi.org/10.1042/BSR20182306.
   PubMed Web of Science ®Google Scholar
• Vassilev LT, Tovar C, Chen S, Knezevic D, Zhao X, Sun H, Heimbrook DC, Chen L. 2006. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc Natl Acad Sci U S A 103:10660–10665. https://doi.org/10.1073/pnas.0600447103.
   PubMed Web of Science ®Google Scholar
• Voets E, Marsman J, Demmers J, Beijersbergen R, Wolthuis R. 2015. The lethal response to Cdk1 inhibition depends on sister chromatid alignment errors generated by KIF4 and isoform 1 of PRC1. Sci Rep 5:14798. https://doi.org/10.1038/srep14798.
   PubMed Web of Science ®Google Scholar
• McCloy RA, Rogers S, Caldon CE, Lorca T, Castro A, Burgess A. 2014. Partial inhibition of Cdk1 in G2 phase overrides the SAC and decouples mitotic events. Cell Cycle 13:1400–1412. https://doi.org/10.4161/cc.28401.
   PubMed Web of Science ®Google Scholar
• Holt LJ, Tuch BB, Villén J, Johnson AD, Gygi SP, Morgan DO. 2009. Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution. Science 325:1682–1686. https://doi.org/10.1126/science.1172867.
   PubMed Web of Science ®Google Scholar
• Cukier IH, Li Y, Lee JM. 2007. Cyclin B1/Cdk1 binds and phosphorylates Filamin A and regulates its ability to cross-link actin. FEBS Lett 581:1661–1672. https://doi.org/10.1016/j.febslet.2007.03.041.
   PubMed Web of Science ®Google Scholar
• Foisner R, Malecz N, Dressel N, Stadler C, Wiche G. 1996. M-phase-specific phosphorylation and structural rearrangement of the cytoplasmic cross-linking protein plectin involve p34cdc2 kinase. Mol Biol Cell 7:273–288. https://doi.org/10.1091/mbc.7.2.273.
   PubMed Web of Science ®Google Scholar
• Blethrow JD, Glavy JS, Morgan DO, Shokat KM. 2008. Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates. Proc Natl Acad Sci U S A 105:1442–1447. https://doi.org/10.1073/pnas.0708966105.
   PubMed Web of Science ®Google Scholar
• Koffa MD, Casanova CM, Santarella R, Köcher T, Wilm M, Mattaj IW. 2006. HURP is part of a Ran-dependent complex involved in spindle formation. Curr Biol 16:743–754. https://doi.org/10.1016/j.cub.2006.03.056.
   PubMed Web of Science ®Google Scholar
• Musacchio A, Desai A. 2017. A molecular view of kinetochore assembly and function. Biology 6:5. https://doi.org/10.3390/biology6010005.
   PubMedGoogle Scholar
• Levine MS, Holland AJ. 2018. The impact of mitotic errors on cell proliferation and tumorigenesis. Genes Dev 32:620–638. https://doi.org/10.1101/gad.314351.118.
   PubMed Web of Science ®Google Scholar
• Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N. 2002. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol 22:7831–7841. https://doi.org/10.1128/mcb.22.22.7831-7841.2002.
   PubMed Web of Science ®Google Scholar
• Shtivelman E, Sussman J, Stokoe D. 2002. A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle. Curr Biol 12:919–924. https://doi.org/10.1016/s0960-9822(02)00843-6.
   PubMed Web of Science ®Google Scholar
• Dangi S, Cha H, Shapiro P. 2003. Requirement for phosphatidylinositol-3 kinase activity during progression through S-phase and entry into mitosis. Cell Signal 15:667–675. https://doi.org/10.1016/s0898-6568(03)00002-0.
   PubMed Web of Science ®Google Scholar
• Liu X, Shi Y, Woods KW, Hessler P, Kroeger P, Wilsbacher J, Wang J, Wang JY, Li C, Li Q, Rosenberg SH, Giranda VL, Luo Y. 2008. Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression. Neoplasia 10:828–837. https://doi.org/10.1593/neo.08408.
   PubMed Web of Science ®Google Scholar
• Warfel NA, Niederst M, Stevens MW, Brennan PM, Frame MC, Newton AC. 2011. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt. J Biol Chem 286:19777–19788. https://doi.org/10.1074/jbc.M111.237081.
   PubMed Web of Science ®Google Scholar
• Kean MJ, Couzens AL, Gingras A-C. 2012. Mass spectrometry approaches to study mammalian kinase and phosphatase associated proteins. Methods 57:400–408. https://doi.org/10.1016/j.ymeth.2012.06.002.
   PubMed Web of Science ®Google Scholar
• Uphoff CC, Drexler HG. 2004. Detecting Mycoplasma contamination in cell cultures by polymerase chain reaction. Methods Mol Med 88:319–326. https://doi.org/10.1385/1-59259-406-9:319.
   PubMedGoogle Scholar
• Liu G, Knight JD, Zhang JP, Tsou CC, Wang J, Lambert JP, Larsen B, Tyers M, Raught B, Bandeira N, Nesvizhskii AI, Choi H, Gingras AC. 2016. Data independent acquisition analysis in ProHits 4.0. J Proteomics 149:64–68. https://doi.org/10.1016/j.jprot.2016.04.042.
   PubMed Web of Science ®Google Scholar
• Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. 1999. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551–3567. https://doi.org/10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2.
   PubMed Web of Science ®Google Scholar
• Eng JK, Jahan TA, Hoopmann MR. 2013. Comet: an open-source MS/MS sequence database search tool. Proteomics 13:22–24. https://doi.org/10.1002/pmic.201200439.
   PubMed Web of Science ®Google Scholar
• Shteynberg D, Deutsch EW, Lam H, Eng JK, Sun Z, Tasman N, Mendoza L, Moritz RL, Aebersold R, Nesvizhskii AI. 2011. iProphet: multi-level integrative analysis of shotgun proteomic data improves peptide and protein identification rates and error estimates. Mol Cell Proteomics 10:M111.007690. https://doi.org/10.1074/mcp.M111.007690.
   PubMed Web of Science ®Google Scholar
• Knight JDR, Choi H, Gupta GD, Pelletier L, Raught B, Nesvizhskii AI, Gingras AC. 2017. ProHits-viz: a suite of web tools for visualizing interaction proteomics data. Nat Methods 14:645–646. https://doi.org/10.1038/nmeth.4330.
   PubMed Web of Science ®Google Scholar
• Meitinger F, Anzola JV, Kaulich M, Richardson A, Stender JD, Benner C, Glass CK, Dowdy SF, Desai A, Shiau AK, Oegema K. 2016. 53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration. J Cell Biol 214:155–166. https://doi.org/10.1083/jcb.201604081.
   PubMed Web of Science ®Google Scholar
• Watson JV, Chambers SH, Smith PJ. 1987. A pragmatic approach to the analysis of DNA histograms with a definable G1 peak. Cytometry 8:1–8. https://doi.org/10.1002/cyto.990080101.
   PubMedGoogle Scholar